Cite
[Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
MLA
Zan, L. K., et al. “[Clinicopathological Analysis of Gastric Adenocarcinoma with Elevated Serum Alpha-Fetoprotein and Enteroblastic Differentiation].” Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology], vol. 46, no. 7, July 2024, pp. 686–95. EBSCOhost, https://doi.org/10.3760/cma.j.cn112152-20230710-00004.
APA
Zan, L. K., Shen, L. L., Zhang, X., Gao, N., Tian, B. G., Geng, X. X., Peng, X., Li, J. W., Bu, P., & Zhao, G. H. (2024). [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology], 46(7), 686–695. https://doi.org/10.3760/cma.j.cn112152-20230710-00004
Chicago
Zan, L K, L L Shen, X Zhang, N Gao, B G Tian, X X Geng, X Peng, J W Li, P Bu, and G H Zhao. 2024. “[Clinicopathological Analysis of Gastric Adenocarcinoma with Elevated Serum Alpha-Fetoprotein and Enteroblastic Differentiation].” Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology] 46 (7): 686–95. doi:10.3760/cma.j.cn112152-20230710-00004.